Drs. Cinar and Picozzi summarize the history of pancreatic cancer treatment options, the challenges associated with treatment and recurrence prevention, and the emerging adjuvant options being studied in current ongoing trials.
Colorectal cancer incidence is increasing in resource-constrained countries among young adults, which could be linked to environmental pollution or lifestyle factors such as obesity, physical inactivity, and a diet rich in processed foods.
RAS mutation analysis should be ordered on all patients with newly diagnosed metastatic colorectal cancer. The goals of therapy should be identified early, including whether the tumor is resectable or borderline resectable, or whether palliative treatment is indicated.
Learn more about the inaugural year of the Maintenance of Certification (MOC) Self-Assessment Activity at the 2015 Gastrointestinal Cancer Symposium through an interview with participant Dr. Joleen Hubbard.
ASCO has partnered with the College of American Pathologists, the American Society for Clinical Pathology, and the Association for Molecular Pathology, to create a guideline on the clinical utility of colorectal cancer biomarkers.
The 12th annual Gastrointestinal Cancers Symposium brought together more than 3,400 attendees, including gastroenterologists, oncologists, surgeons, radiation oncologists, pathologists, and other members of the cancer care community.